NL-OMON55579已完成不适用
Registry of Treatment Outcomes in a non-study population of Symptomatic Metastasized Castration Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223 (ROTOR-registry). - Radium-223 in mCRPC patients registry/ROTOR-registry
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational non invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- At the physicians discretion
- •- Written informed consent
- •- Age 18 year of older
排除标准
- •- At the physicians discretion
研究者
相似试验
招募中
不适用
Registry of Treatment Outcomes in a non-study population of Symptomatic Metastasized Castration Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223 (ROTOR-registry)Radium-223prostate cancerNL-OMON19873etherlands Cancer Institute-Antoni van Leeuwenhoek hospital300
招募中
Unknown
To evaluate safety and benefit of Ahaglow (GlycOlic acid, Aloe veRa and Vitamin-E) based face wash for daily use in Acne Prone SkiCTRI/2023/06/053763Torrent Pharmaceuticals Ltd,
已完成
不适用
Observational study for treatment outcome in patients with HER2-positive metastatic breast cancer who received pertuzumab combination chemotherapy.Breast cancerJPRN-UMIN000012210Kurume University Hospital10
已完成
Unknown
To check the safety and benefit of Ahaglow Gentle Cleanser for daily use in dry sensitive skiCTRI/2023/06/053708Torrent Pharmaceuticals Ltd,568
暂停
不适用
Web-based Intervention for Employees with DepressioWork productivity (work absenteeism and presenteeism)Mental Health - DepressionDepressionACTRN12612000035820Dr Leanne Casey40